Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
earnings-growth: Archive
Wall Street Bulls Look Optimistic About Novo Nordisk (NVO): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Novo Nordisk (NVO). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
NVOPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Marvell (MRVL) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Marvell (MRVL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
MRVLPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Portillo's Inc. (PTLO) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Portillo's Inc. (PTLO) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
PTLOPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
3 Reasons Why Growth Investors Shouldn't Overlook Texas Roadhouse (TXRH)
by Zacks Equity Research
Texas Roadhouse (TXRH) possesses solid growth attributes, which could help it handily outperform the market.
TXRHNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Growth Investors Will Love Zynex (ZYXI)
by Zacks Equity Research
Zynex (ZYXI) is well positioned to outperform the market, as it exhibits above-average growth in financials.
ZYXIPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Here is Why Growth Investors Should Buy Frontdoor (FTDR) Now
by Zacks Equity Research
Frontdoor (FTDR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
FTDRPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Here is Why Growth Investors Should Buy Green Brick Partners (GRBK) Now
by Zacks Equity Research
Green Brick Partners (GRBK) possesses solid growth attributes, which could help it handily outperform the market.
GRBKNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
Here is Why Growth Investors Should Buy Lancaster Colony (LANC) Now
by Zacks Equity Research
Lancaster Colony (LANC) possesses solid growth attributes, which could help it handily outperform the market.
LANCPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Looking for a Growth Stock? 3 Reasons Why Commvault (CVLT) is a Solid Choice
by Zacks Equity Research
Commvault (CVLT) possesses solid growth attributes, which could help it handily outperform the market.
CVLTNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Why Growth Investors Shouldn't Overlook EOG Resources (EOG)
by Zacks Equity Research
EOG Resources (EOG) possesses solid growth attributes, which could help it handily outperform the market.
EOGNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Why Growth Investors Shouldn't Overlook Abercrombie (ANF)
by Zacks Equity Research
Abercrombie (ANF) possesses solid growth attributes, which could help it handily outperform the market.
ANFPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Is Brinker International (EAT) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Brinker International (EAT) could produce exceptional returns because of its solid growth attributes.
EATPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Wall Street Analysts Think Seanergy Maritime Holdings (SHIP) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Seanergy Maritime Holdings (SHIP) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
SHIPNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Archrock Inc. (AROC) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Archrock Inc. (AROC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
AROCNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Prologis (PLD): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Prologis (PLD) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
PLDPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Nike (NKE): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Nike (NKE). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
NKEPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Criteo (CRTO) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Criteo (CRTO) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CRTOPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Diamondback (FANG) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Diamondback (FANG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
FANGNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think JD.com (JD) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in JD.com (JD). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
JDPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Roblox (RBLX) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Roblox (RBLX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
RBLXPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
SentinelOne (S) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), SentinelOne (S) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
SPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Leidos (LDOS) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Leidos (LDOS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
LDOSNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is BrightSphere Investment Group (BSIG) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
BrightSphere Investment Group (BSIG) possesses solid growth attributes, which could help it handily outperform the market.
BSIGNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
United Therapeutics (UTHR) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
United Therapeutics (UTHR) possesses solid growth attributes, which could help it handily outperform the market.
UTHRPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Why Growth Investors Shouldn't Overlook Civitas (CIVI)
by Zacks Equity Research
Civitas (CIVI) possesses solid growth attributes, which could help it handily outperform the market.
CIVINegative Net Change
earnings-growth growth-investing growth-investors growth-stocks